UCB SA (UCBJY)
OTCMKTS · Delayed Price · Currency is USD
150.37
+1.44 (0.97%)
Oct 13, 2025, 3:44 PM EDT
UCB SA Market Cap
UCB SA has a market cap or net worth of $57.15 billion as of October 14, 2025. Its market cap has increased by 65.42% in one year.
Market Cap
57.15B
Enterprise Value
58.62B
Revenue
8.04B
Ranking
n/a
PE Ratio
36.54
Stock Price
$150.37
Market Cap Chart
Since April 5, 1995, UCB SA's market cap has increased from 1.20B to 57.15B, an increase of 4,660.27%. That is a compound annual growth rate of 13.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 13, 2025 | 57.15B | 51.40% |
| Dec 31, 2024 | 37.75B | 128.16% |
| Dec 29, 2023 | 16.55B | 10.80% |
| Dec 30, 2022 | 14.93B | -30.70% |
| Dec 31, 2021 | 21.55B | 10.36% |
| Dec 31, 2020 | 19.53B | 30.28% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 671.65M |
| Glass House Brands | 650.22M |
| Veradigm | 525.44M |
| Northwest Biotherapeutics | 378.75M |
| CytoDyn | 335.98M |
| Nika Pharmaceuticals | 333.67M |
| American Oncology Network | 283.44M |
| Silence Therapeutics | 236.17M |